Matches in Nanopublications for { <http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT> ?p ?o ?g. }
- OBJECT label "to produce eight treatment groups in two independent trials" provenance.
- OBJECT label "to produce eight treatment groups in two independent trials" provenance.
- OBJECT label "to produce eight treatment groups in two independent trials" provenance.
- OBJECT label "in five COVID-19 infected patients with acute respiratory distress syndrome" provenance.
- OBJECT label "in five COVID-19 infected patients with acute respiratory distress syndrome" provenance.
- OBJECT label "in five COVID-19 infected patients with acute respiratory distress syndrome" provenance.
- OBJECT label "web-, with allocation concealment" provenance.
- OBJECT label "web-, with allocation concealment" provenance.
- OBJECT label "web-, with allocation concealment" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label "as an alternative therapeutic option for Canine, in veterinary medicine" provenance.
- OBJECT label ""Dex ) s therapeutic activity in severe cases of COVID-19 patients"" provenance.
- OBJECT label ""Dex ) s therapeutic activity in severe cases of COVID-19 patients"" provenance.
- OBJECT label ""Dex ) s therapeutic activity in severe cases of COVID-19 patients"" provenance.
- OBJECT label ""Dex ) s therapeutic activity in severe cases of COVID-19 patients"" provenance.
- OBJECT label ""Dex ) s therapeutic activity in severe cases of COVID-19 patients"" provenance.
- OBJECT label ""Dex ) s therapeutic activity in severe cases of COVID-19 patients"" provenance.
- OBJECT label "a decrease" provenance.
- OBJECT label "a decrease" provenance.
- OBJECT label "a decrease" provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021–0.36 " provenance.
- OBJECT label "plasma angiotensin ( ANG ) I and ANG II" provenance.
- OBJECT label "plasma angiotensin ( ANG ) I and ANG II" provenance.
- OBJECT label "plasma angiotensin ( ANG ) I and ANG II" provenance.
- OBJECT label "plasma angiotensin ( ANG ) I and ANG II" provenance.
- OBJECT label "plasma angiotensin ( ANG ) I and ANG II" provenance.
- OBJECT label "plasma angiotensin ( ANG ) I and ANG II" provenance.
- OBJECT label "plasma angiotensin ( ANG ) I and ANG II" provenance.
- OBJECT label "plasma angiotensin ( ANG ) I and ANG II" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.
- OBJECT label "to treat COVID-19 but many report residual mental health problems after recovery" provenance.